FDA Issues Warning to AeroShot Manufacturers

According to an article by in the Huffington Post, the FDA announced today that it had issued a warning letter to Breathable Foods, the manufacturers of the caffeine inhaler known as Aeroshot, for "false or misleading statements" in the advertising for its controversial new product.
The FDA took questioned several of AeroShot's claims, especially the idea that the caffeine inhaler delivers "breathable energy" but is "intended to be ingested by swallowing." The FDA's press release notes that, "A product cannot be intended for both inhalation and ingestion.” These are two separate bodily functions.

The FDA was also worried about the possibility that AeroShot was marketing its product to teens as a fun complement to alcoholic beverages.  Due to prior incidents, the FDA has little patience for dangerous caffeine-alcohol mash-ups.
Breathable Foods indicated that it would cooperate with the terms of the FDA's warning letter. “We plan to work closely with the FDA to meet their requests for information and labeling changes to ensure compliance with dietary supplement requirements," Breathable Foods CEO Tom Hadfield said in a statement. "AeroShot delivers a mix of B vitamins and caffeine to the mouth for ingestion and is not 'inhaled' into the lungs. AeroShot is not recommended or marketed to persons under 18 or for use with alcohol."

So far, all this controversy seems to have actually boosted sales of AeroShot. Breathable Foods says that AeroShots remain available on store shelves in Boston and New York but are completely sold out on the company's website.